The decrease in breast-cancer incidence in 2003 in the United States.

被引:692
作者
Ravdin, Peter M.
Cronin, Kathleen A.
Howlader, Nadia
Berg, Christine D.
Chlebowski, Rowan T.
Feuer, Eric J.
Edwards, Brenda K.
Berry, Donald A.
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA
[2] NCI, Div Canc Control & Populat Sci, Bethesda, MD 20892 USA
[3] NCI, Div Canc Prevent, Bethesda, MD 20892 USA
[4] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA
关键词
D O I
10.1056/NEJMsr070105
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
An initial analysis of data from the National Cancer Institute's Surveillance, Epidemiology, and End Results ( SEER) registries shows that the age-adjusted incidence rate of breast cancer in women in the United States fell sharply ( by 6.7%) in 2003, as compared with the rate in 2002. Data from 2004 showed a leveling off relative to the 2003 rate, with little additional decrease. Regression analysis showed that the decrease began in mid-2002 and had begun to level off by mid-2003. A comparison of incidence rates in 2001 with those in 2004 ( omitting the years in which the incidence was changing) showed that the decrease in annual age-adjusted incidence was 8.6% (95% confidence interval [CI], 6.8 to 10.4). The decrease was evident only in women who were 50 years of age or older and was more evident in cancers that were estrogen-receptor - positive than in those that were estrogen-receptor - negative. The decrease in breast-cancer incidence seems to be temporally related to the first report of the Women's Health Initiative and the ensuing drop in the use of hormone-replacement therapy among postmenopausal women in the United States. The contributions of other causes to the change in incidence seem less likely to have played a major role but have not been excluded.
引用
收藏
页码:1670 / 1674
页数:5
相关论文
共 17 条
[1]  
Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0
[2]  
Beral V, 1997, LANCET, V350, P1047, DOI 10.1016/S0140-6736(97)08233-0
[3]   Effect of screening and adjuvant therapy on mortality from breast cancer [J].
Berry, DA ;
Cronin, KA ;
Plevritis, SK ;
Fryback, DG ;
Clarke, L ;
Zelen, M ;
Mandelblatt, JS ;
Yakovlev, AY ;
Habbema, JDF ;
Feuer, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (17) :1784-1792
[4]   Hormone therapy prescribing patterns in the United States [J].
Buist, DSM ;
Newton, KM ;
Miglioretti, DL ;
Beverly, K ;
Connelly, MT ;
Andrade, S ;
Hartsfield, CL ;
Wei, FF ;
Chan, KA ;
Kessler, L .
OBSTETRICS AND GYNECOLOGY, 2004, 104 (05) :1042-1050
[5]  
Clarke Christina A, 2006, J Clin Oncol, V24, pe49, DOI 10.1200/JCO.2006.08.6504
[6]   Tamoxifen for prevention of breast cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 study [J].
Fisher, B ;
Costantino, JP ;
Wickerham, DL ;
Redmond, CK ;
Kavanah, M ;
Cronin, WM ;
Vogel, V ;
Robidoux, A ;
Dimitrov, N ;
Atkins, J ;
Daly, M ;
Wieand, S ;
Tan-Chiu, E ;
Ford, L ;
Wolmark, N .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1371-1388
[7]  
Freedman Andrew N., 2004, EJC Supplements, V2, P17
[8]   National use of postmenopausal hormone therapy - Annual trends and response to recent evidence [J].
Hersh, AL ;
Stefanick, ML ;
Stafford, RS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (01) :47-53
[9]   Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among US Hispanic/Latino populations [J].
Howe, Holly L. ;
Wu, Xiaocheng ;
Ries, Lynn A. G. ;
Cokkinides, Vilma ;
Ahmed, Faruque ;
Jemal, Ahmedin ;
Miller, Barry ;
Williams, Melanie ;
Ward, Elizabeth ;
Wingo, Phyllis A. ;
Ramirez, Amelie ;
Edwards, Brenda K. .
CANCER, 2006, 107 (08) :1711-1742
[10]   Cancer statistics, 2007 [J].
Jemal, Ahmedin ;
Siegel, Rebecca ;
Ward, Elizabeth ;
Murray, Taylor ;
Xu, Jiaquan ;
Thun, Michael J. .
CA-A CANCER JOURNAL FOR CLINICIANS, 2007, 57 (01) :43-66